<DOC>
	<DOCNO>NCT00770458</DOCNO>
	<brief_summary>Validate circulate cell free fetal nucleic acid use identify direct marker fetal aneuploidy , particularly fetal Down Syndrome ( DS ) , good surrogate marker .</brief_summary>
	<brief_title>Non-Invasive Screening Fetal Aneuploidy : A New Maternal Plasma Marker</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Subject female Subject pregnant Subject high risk aneuploid patient undergoing genetic counseling , unltrasound screening , amniocentesis and/or CVS procedure Subject willing provide blood specimen Subject pregnant Subject willing provide blood specimen Subject have aneuploid screening</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Down Syndrome</keyword>
</DOC>